Radioterapi pada Karsinoma Sel Basal

- Fatmasari; H.M Djakaria

doi:10.32532/jori.v8i2.68

Radioterapi pada Karsinoma Sel Basal

- Fatmasari, H.M Djakaria

Sari

Karsinoma sel basal (KSB) merupakan kanker kulit yang paling sering terjadi, bersifat slow growing, invasif lokal, agresif dan destruktif lokal, jarang bermetastasis, namun dapat menyebabkan kerusakan jaringan lokal dan cacat fungsional. Radioterapi sebagai terapi utama dalam kondisi tertentu mampu memberikan hasil yang baik. Begitu pula sebagai terapi adjuvan, radioterapi terbukti mampu menurunkan angka rekurensi dengan konsekuensi kosmetik minimal dan efek samping yang dapat ditoleransi. Oleh karena itu, pertimbangan radioterapi dalam tatalaksana KSB harus dimasukkan ke dalam pengambilan keputusan klinis dan manajemen multidisiplin.

Kata Kunci

Radiasi; Karsinoma sel basal; Non melanoma malignum

Teks Lengkap:

PDF

Referensi

Carucci JA, Leff el DJ. Basal cell carcinoma. In: Wolff K, Goldsmith LA, Katz SI, GLicherst BA, Paller AS, Leffel LJ, editors. Fitzpatrick’s dermatology in general medicine. 7th ed. New York. Mc Graw-Hill; 2008.

Cipto H, Pratomo U.S et al. Deteksi dan penatalaksanaan kanker kulit dini, FKUI Jakarta; 2001.

Ansarin H, Daliri M, Arabhsari RS. Expression of p53

in aggressive and non aggressive histologic variant of basal cell carcinoma. European Journal of Dermatology. 2006; 16(5): 543-7.

Tang JY, Xiao TZ, Oda Y, Chang KS, Shpall E, Wu A, et al. Vitamin D3 inhibits hedgehog signaling and proliferation in murine basal cell carcinoma. Cancer Prev Res (Phila). 2011; 4(5): 744-51.

Rass K, Reinchrath J. UV damage and DNA repair in malignant melanoma and non-melanoma skin cancer. In: Reinchrath J, editor. Sunlight, vitamin D and skin cancer. Verlag New York. Springer; 2008.

Cohen P, Schulze K, Nelson B. Basal cell carcinoma with mixed histology: a possible pathogenesis for recurrent skin cancer. Dermatol Surg. 2006; 32(4): 542-51.

Crowson AN. Basal cell carcinoma: biology, morphology and clinical implications. Modern pathology. 2006; 19: 127-47.

Rubin AI, Chen EH, Ratner D. Basal cell carcinoma. N Engl J Med. 2005; 353: 2262-9.

Naraghi Z, Ghaninejad H, Akhyani. Akbari D. Cytological diagnosis of cutaneous basal cell carcinoma. Acta Medica Iranica. 2005; 43: 50-4.

Ghaderi R, Haghighi F. Immunohistochemistry assessment of p53 protein in basal cell carcinoma. Iran J Allergy Asthma Immunol. 2005; 4: 167-71.

American Joint Committee on Cancer. Cutaneus squamous cell carcinoma and other cutaneous carcinoma. In: Cancer staging handbook, 7th ed. Chicago: Springer Nature; 2010.

Zadgrodnik B, Kempf W, Seifert B, Müller B, Burg G, Urosevic M, Dummer R. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2. Cancer. 2003; 98: 2708-14.

N.R.Telfer,Colver GB, Bowers PW. Guidelines for the management of basal cell carcinoma. BJ of Dermatology.1999; 141: 415-23.

Bindu V, Manyam, MD; Nikhil Joshi, MD; Shlomo A. Koyfman, MD. A review of the role of external-beam radiation therapy in non melanomatous skin cancer. Applied Radiation Oncology. 2017 June; 6(2):6-10

Koyfman SA,Cooper JS, Beitler JJ, Busse PM, Jones CU, McDonald MW, Quon H, Ridge JA, Saba NF, Salama JK, Siddiqui F, Smith RV, Worden F, Yao M, Yom SS. Appropriateness criteria aggressive non melanomatous skin cancer of the head and neck. Head neck. 2016; 38(2): 175-

Khan. Radiother Oncol. 2012; DOI:10.1016/j.radonc.2012.06.013.

Venness MJ, Richards S et al. Radiotherapy. Chapter 139. In: Bolognia JL, eds. Dermatology, 3rd ed. London: Elsevier; 2012.

National Comprehensive Cancer Network (NCCN) Clinical Practical Guidelines in Oncology Basal Cell Skin Cancer, Version 1.2017

Avril MF, Auperin A, Margulis A, Gerbaulet A, Duvillard P, Benhamou E, Guillame JC, Chalon R, Petit JY, Sancho-Garnier H, Prade M, Bouzy J,Chassagne D. Basal cell carcinoma of the face: surgery or radiotherapy? results of a randomized study. British Journal of Cancer. 1997; 76(1):100-06.

Caccialanza MI, Piccinno R, Grammatica A. Radiotherapy of recurrent basal and squamous cell skin carcinomas: a study of 249 re-treated carcinomas in 229 patients. Eur J Dermatol. 2001 Jan; 11(1):25-8.

DOI: https://doi.org/10.32532/jori.v8i2.68 <